Ferne M, BERGNER-RABINOWITZ S, Ginsburg I
Inflammation. 2013; 1(3):247-60.
PMID: 24194449
DOI: 10.1007/BF00917866.
Neuhaus F, Baddiley J
Microbiol Mol Biol Rev. 2003; 67(4):686-723.
PMID: 14665680
PMC: 309049.
DOI: 10.1128/MMBR.67.4.686-723.2003.
Ginsburg I, Mitra R, GIBBS D, Varani J, Kohen R
Inflammation. 1993; 17(3):295-319.
PMID: 8330929
DOI: 10.1007/BF00918992.
Courtney H, Ofek I, Simpson W, Beachey E
Infect Immun. 1981; 32(2):625-31.
PMID: 7019075
PMC: 351492.
DOI: 10.1128/iai.32.2.625-631.1981.
Sela M, Natan G, Lahav M, Ginsburg I, DISHON T
Inflammation. 1980; 4(2):195-203.
PMID: 6771214
DOI: 10.1007/BF00914165.
Association of elevated levels of cellular lipoteichoic acids of group B streptococci with human neonatal disease.
Nealon T, Mattingly S
Infect Immun. 1983; 39(3):1243-51.
PMID: 6341233
PMC: 348090.
DOI: 10.1128/iai.39.3.1243-1251.1983.
Binding of streptococcal lipoteichoic acid to fatty acid-binding sites on human plasma fibronectin.
Courtney H, Simpson W, Beachey E
J Bacteriol. 1983; 153(2):763-70.
PMID: 6337126
PMC: 221695.
DOI: 10.1128/jb.153.2.763-770.1983.
Pretreatment with lipoteichoic acid sensitizes target cells to antibody-dependent cellular cytotoxicity in the presence of anti-lipoteichoic acid antibodies.
Lopatin D, Kessler R
Infect Immun. 1985; 48(3):638-43.
PMID: 3997238
PMC: 261214.
DOI: 10.1128/iai.48.3.638-643.1985.
Relationship of critical micelle concentrations of bacterial lipoteichoic acids to biological activities.
Courtney H, Simpson W, Beachey E
Infect Immun. 1986; 51(2):414-8.
PMID: 3943894
PMC: 262343.
DOI: 10.1128/iai.51.2.414-418.1986.
Lipoteichoic acid-antilipoteichoic acid complexes induce superoxide generation by human neutrophils.
Ginsburg I, Fligiel S, Ward P, Varani J
Inflammation. 1988; 12(6):525-48.
PMID: 2851550
DOI: 10.1007/BF00914316.
Interaction of mammalian cells with polymorphonuclear leukocytes: relative sensitivity to monolayer disruption and killing.
Ginsburg I, GIBBS D, Varani J
Inflammation. 1989; 13(5):529-42.
PMID: 2807519
DOI: 10.1007/BF00916759.
Streptococcus pyogenes clinical isolates and lipoteichoic acid.
Leon O, Panos C
Infect Immun. 1990; 58(11):3779-87.
PMID: 2228247
PMC: 313728.
DOI: 10.1128/iai.58.11.3779-3787.1990.
Stimulation of oxidative burst in human monocytes by lipoteichoic acids.
Levy R, Kotb M, Nagauker O, Majumdar G, Alkan M, Ofek I
Infect Immun. 1990; 58(2):566-8.
PMID: 2153634
PMC: 258495.
DOI: 10.1128/iai.58.2.566-568.1990.
Heterogeneity of lipoteichoic acid detected by anion exchange chromatography.
Leopold K, Fischer W
Arch Microbiol. 1992; 157(5):446-50.
PMID: 1510570
DOI: 10.1007/BF00249103.
Immunogenicity of a purified and carrier-complexed streptococcal lipoteichoic acid.
Fiedel B, Jackson R
Infect Immun. 1976; 13(6):1585-90.
PMID: 786876
PMC: 420804.
DOI: 10.1128/iai.13.6.1585-1590.1976.
Lipid-free glycerol teichoic acids with potent membrane-binding activity.
COOPER H, CHORPENNING F, Roses S
Infect Immun. 1978; 19(2):462-9.
PMID: 564877
PMC: 414106.
DOI: 10.1128/iai.19.2.462-469.1978.
Inflammatory lesions and bone resorption induced in the rat periodontium by lipoteichoic acid of Streptococcus mutans.
Bab I, Sela M, Ginsburg I, DISHON T
Inflammation. 1979; 3(4):345-58.
PMID: 511295
DOI: 10.1007/BF00913493.
Binding of lipoteichoic acid of group A streptococci to isolated human erythrocyte membranes.
Chiang T, Alkan M, Beachey E
Infect Immun. 1979; 26(1):316-21.
PMID: 387608
PMC: 414614.
DOI: 10.1128/iai.26.1.316-321.1979.
Immunogenicity of soluble versus cellular glycerol teichoic acid.
CHORPENNING F, COOPER H, Oldfather J, Lynch Jr J
Infect Immun. 1979; 26(1):211-6.
PMID: 387604
PMC: 414597.
DOI: 10.1128/iai.26.1.211-216.1979.
Erythrocyte binding properties of streptococcal lipoteichoic acids.
Beachey E, Dale J, Simpson W, Evans J, KNOX K, Ofek I
Infect Immun. 1979; 23(3):618-25.
PMID: 378832
PMC: 414210.
DOI: 10.1128/iai.23.3.618-625.1979.
